Mechanisms by which cysteine can inhibit or promote the oxidation of low density lipoprotein by copper

Atherosclerosis

Volumn 169, Issue 1, 2003, Pages 87-94

  Patterson, Rebecca A ^a   Lamb, David J ^a,b   Leake, David S ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Antioxidant; Atherosclerosis; Copper; Cysteine; Cystine; Oxidized low density lipoprotein; Prooxidant

Indexed keywords

COPPER ION; CYSTEINE; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY RISK; DECOMPOSITION; ENZYME ACTIVITY; HUMAN; LIPID HYDROLYSIS; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; REDUCTION;

EID: 0037630625     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00154-0     Document Type: Article

References (46)

1. Gerrity R.G., Naito H.K., Richardson M., Schwartz C.J. Dietary induced atherogenesis in swine. I. Morphology of the intima in prelesional stages. Am. J. Pathol. 95:1979;775-792.
2. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883-3887.
3. Parthasarathy S. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim. Biophys. Acta. 917:1987;337-340.
4. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:1987;10098-10103.
5. Sparrow C.P., Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34:1993;1219-1228.
6. Graham A., Wood J.L., O'Leary V.J., Stone D. Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism. Free Radic. Res. 21:1994;295-308.
7. Fujiwara K., Sato H., Bannai S. Involvement of endotoxins or tumor necrosis factor-α in macrophage-mediated oxidation of low density lipoprotein. FEBS Lett. 431:1998;116-120.
8. Graham A. Cellular thiol production and oxidation of low-density lipoprotein. Free Radic. Res. 28:1998;611-621.
9. Santanam N., Parthasarathy S. Cellular cysteine generation does not contribute to the initiation of LDL oxidation. J. Lipid Res. 36:1995;2203-2211.
10. Lynch S.M., Frei B. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim. Biophys. Acta. 1345:1997;215-221.
11. Ferns G.A.A., Lamb D.J., Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis. 133:1997;139-152.
12. Smith C., Mitchinson M.J., Aruoma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxy radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286:1992;901-905.
13. Swain J., Gutteridge J.M.C. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett. 368:1995;513-515.
14. Lamb D.J., Mitchinson M.J., Leake D.S. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Lett. 374:1995;12-16.
15. Evans P.J., Smith C., Mitchinson M.J., Halliwell B. Metal ion release from mechanically-disrupted human arterial wall - implications for the development of atherosclerosis. Free Radic. Res. 23:1995;465-469.
16. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272:1997;3520-3526.
17. Fu S., Davies M.J., Stocker R., Dean R.T. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem. J. 333:1998;519-525.
18. Araki A., Sako Y., Fukushima Y., Matsumoto M., Asada T., Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis. 79:1989;139-146.
19. Mansoor M.A., Bergmark C., Svardal A.M., Lonning P.E., Ueland P.M. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler. Thromb. Vasc. Biol. 15:1995;232-240.
20. 12, and folate. Am. J. Epidemiol. 143:1996;845-859.
21. Jacob N., Bruckert E., Giral P., Foglietti M.J., Turpin G. Cysteine is a cardiovascular risk factor in hyperlipidemic patients. Atherosclerosis. 146:1999;53-59.
22. van den Brandhof W.E., Haks K., Schouten E.G., Verhoef P. The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis. 157:2001;403-409.
23. El-Khairy L., Ueland P.M., Refsum H., Graham I.M., Vollset S.E. Plasma total cysteine as a risk factor for vascular disease - the European Concerted Action project. Circulation. 103:2001;2544-2549.
24. Wilkins G.M., Leake D.S. The effect of inhibitors of free radical generating-enzymes on low-density lipoprotein oxidation by macrophages. Biochim. Biophys. Acta. 1211:1994;69-78.
25. Schacterle G.R., Pollack R.L. A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal. Biochem. 51:1973;654-655.
26. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6:1989;67-75.
27. Roland A., Patterson R.A., Leake D.S. Measurement of copper-binding sites on low density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 21:2001;594-602.
28. Lynch S.M., Frei B. Reduction of copper, but not iron, by human low density lipoprotein (LDL) - implications for metal ion-dependent oxidative modification of LDL. J. Biol. Chem. 270:1995;5158-5163.
29. El-Saadani M., Esterbauer H., El-Sayed M., Goher M., Nassar A.Y., Jürgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30:1989;627-630.
30. Andersson A., Hultberg B., Lindgren A. Redox status of plasma homocysteine and other plasma thiols in stroke patients. Atherosclerosis. 151:2000;535-539.
31. Brigham M.P., Stein W.H., Moore S. The concentration of cysteine and cystine in human blood plasma. J. Clin. Invest. 39:1960;1633-1638.
32. Ziouzenkova O., Sevanian A., Abuja P.M., Ramos P., Esterbauer H. Copper can promote oxidation of LDL by markedly different mechanisms. Free Radic. Biol. Med. 24:1998;607-623.
33. Heinecke J.W., Kawamura M., Suzuki L., Chait A. Oxidation of low-density-lipoprotein by thiols - superoxide-dependent and superoxide-independent mechanisms. J. Lipid Res. 34:1993;2051-2061.
34. Heinecke J.W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74:1984;1890-1894.
35. Leake D.S., Rankin S.M. The oxidative modification of low-density lipoproteins by macrophages. Biochem. J. 270:1990;741-748.
36. Kritharides L., Jessup W., Dean R.T. Macrophages require both iron and copper to oxidize low density lipoprotein in Hanks balanced salt solution. Arch. Biochem. Biophys. 323:1995;127-136.
37. Mukhopadhyay C.K., Ehrenwald E., Fox P.L. Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism. J. Biol. Chem. 271:1996;14773-14778.
38. Burkitt M.J. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, α-tocopherol, thiols, and ceruloplasmin. Arch. Biochem. Biophys. 394:2001;117-135.
39. Bowry V.W., Ingold K.U., Stocker R. Vitamin E in human low-density lipoprotein - when and how this antioxidant becomes a prooxidant. Biochem. J. 288:1992;341-344.
40. Lappin A.G., Youngblood M.P., Margerum D.W. Electron-transfer reactions of copper(I) and copper(II) complexes. Inorg. Chem. 19:1980;407-413.
41. I-complexes. J. Chem. Soc. Perkin Trans. 2:1999;1115-1121.
42. Patel R.P., Svistunenko D., Wilson M.T., Darley-Usmar V.M. Reduction of Cu(II) by lipid hydroperoxides: implications for the copper-dependent oxidation of low-density lipoprotein. Biochem. J. 322:1997;425-433.
43. Wilcox A.L., Marnett L.J. Polyunsaturated fatty acid alkoxyl radicals exist as carbon-centered epoxyallylic radicals - a key step in hydroperoxide-amplified lipid peroxidation. Chem. Res. Toxicol. 6:1993;413-416.
44. Esterbauer H., Gebicki J., Puhl H., Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
45. Lamb D.J., Leake D.S. The effect of EDTA on the oxidation of low density lipoprotein. Atherosclerosis. 94:1992;35-42.
46. Dawson R.M.C., Elliott D.C., Elliott W.H., Jones K.M. Data for Biochemical Research. 1986;Clarendon Press, Oxford.